Skip Navigation LinksHome > May 2014 - Volume 9 - Issue 5 > Contributor Index

May 2014 - Volume 9 - Issue 5 - Contributor Index

View All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Other
Actions
View
Show
Previous of 11 Next
Author Name Article
Altorki, Nasser K. MD

Outcomes of Unresected Ground-Glass Nodules with Cytology Suspicious for Adenocarcinoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
An, She-Juan PhD

MET Expression Plays Differing Roles in Non–Small-Cell Lung Cancer Patients with or without EGFR Mutation

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Anoop, T.M. MD

Primary Osteosarcoma of Rib Mimicking Lung Mass with Secondary Aneurysmal Bone Cyst Formation

Purchase Access
PDF
+ Favorites
Request Permissions
Arce-Lara, Carlos MD

Cisplatin versus Carboplatin-Based Regimens for the Treatment of Patients with Metastatic Lung Cancer. An Analysis of Veterans Health Administration Data

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Babanrao, Sabale Avinash DMRD, DNB

Primary Osteosarcoma of Rib Mimicking Lung Mass with Secondary Aneurysmal Bone Cyst Formation

Purchase Access
PDF
+ Favorites
Request Permissions
Badve, Sunil S. MD

ITMIG Consensus Statement on the Use of the WHO Histological Classification of Thymoma and Thymic Carcinoma: Refined Definitions, Histological Criteria, and Reporting

Free Access
Abstract
PDF
+ Favorites
Request Permissions
Barni, Sandro MD

Phase II Randomized Study of Vandetanib Plus Gemcitabine or Gemcitabine Plus Placebo as First-Line Treatment of Advanced Non–Small-Cell Lung Cancer in Elderly Patients

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Bartholmai, Brian J. MD

Correlation of Regional Emphysema and Lung Cancer: A Lung Tissue Research Consortium-Based Study

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Behrens, Carmen MD

Membrane Carbonic Anhydrase IX Expression and Relapse Risk in Resected Stage I–II Non–Small-Cell Lung Cancer

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Bell, Jennifer M. BSN

National Patterns of Care and Outcomes After Combined Modality Therapy for Stage IIIA Non–Small-Cell Lung Cancer

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Bitterman, Peter B. MD

Correlation of Regional Emphysema and Lung Cancer: A Lung Tissue Research Consortium-Based Study

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Bootsma, Gerben MD, PhD

A Phase I Study of Concurrent Individualized, Isotoxic Accelerated Radiotherapy and Cisplatin–Vinorelbine–Cetuximab in Patients With Stage III Non–Small-Cell Lung Cancer

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Bowles, Erin J. Aiello MPH

Comparative Effectiveness of Adjunctive Bevacizumab for Advanced Lung Cancer: The Cancer Research Network Experience

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Bradley, Jeffrey D. MD

National Patterns of Care and Outcomes After Combined Modality Therapy for Stage IIIA Non–Small-Cell Lung Cancer

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Brandes, Alba Ariela MD

Phase II Randomized Study of Vandetanib Plus Gemcitabine or Gemcitabine Plus Placebo as First-Line Treatment of Advanced Non–Small-Cell Lung Cancer in Elderly Patients

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Brans, Boudewijn MD, PhD

A Phase I Study of Concurrent Individualized, Isotoxic Accelerated Radiotherapy and Cisplatin–Vinorelbine–Cetuximab in Patients With Stage III Non–Small-Cell Lung Cancer

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Bria, Emilio MD

ALK/EML4 Fusion Gene May Be Found in Pure Squamous Carcinoma of the Lung

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Brooks, Angela N. PhD

Breaking Down RET Breakpoints in Lung Adenocarcinoma

Purchase Access
PDF
+ Favorites
Request Permissions
Brunelli, Matteo MD, PhD

ALK/EML4 Fusion Gene May Be Found in Pure Squamous Carcinoma of the Lung

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Caffo, Orazio MD

Phase II Randomized Study of Vandetanib Plus Gemcitabine or Gemcitabine Plus Placebo as First-Line Treatment of Advanced Non–Small-Cell Lung Cancer in Elderly Patients

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Actions
View
Show
Previous of 11 Next